Is Caffeine Bad for Autoimmune Disease?

Caffeine is not uniformly harmful for autoimmune disease, and for several autoimmune conditions, the evidence leans in the opposite direction. The relationship between caffeine and the immune system is genuinely complicated: caffeine can dial down some inflammatory pathways while ramping up others, and the net effect depends on the specific disease, the dose, and the person drinking the coffee. Research on conditions like multiple sclerosis, lupus, and inflammatory bowel disease suggests caffeine may be protective, while the picture for rheumatoid arthritis is murkier and the practical question of drug interactions adds another layer entirely.

How Caffeine Interacts with the Immune System

Caffeine’s primary move in the body is blocking adenosine receptors, and adenosine is one of the immune system’s natural brakes. When caffeine sits on those receptors, it can change how immune cells behave in ways that cut in both directions. In lab studies using cells from rheumatoid arthritis patients, caffeine’s blockade of one specific receptor (A2a) ramped up the production of an inflammatory signaling molecule called IFN-gamma in a subset of immune cells, suggesting it could theoretically promote inflammation in that context.¹ But the same mechanism does not produce the same result in every cell type. In one type of macrophage (a key immune cell), caffeine suppressed the inflammatory molecule TNF-alpha while boosting others like IL-6 and IL-1-beta; in a different macrophage subtype, it suppressed TNF-alpha without increasing those other signals at all.²

Animal studies add another dimension. In mice challenged with a bacterial infection, caffeine reduced the expression of several pro-inflammatory markers and increased the anti-inflammatory molecule IL-10.³ And at the genetic level, high-dose caffeine has been shown to broadly suppress inflammatory gene activity, including genes directly implicated in lupus and rheumatoid arthritis, with some of these effects kicking in at concentrations equivalent to a single cup of coffee. The overall pattern is that caffeine is not simply pro-inflammatory or anti-inflammatory. It reshapes immune signaling in ways that depend on dose, cell type, and the inflammatory environment already present.

Dose seems to be a particularly important variable. A review of caffeine’s immunomodulatory properties found that macrophages and natural killer cells showed increased activity at low caffeine doses but reduced activity at high doses.⁴ This biphasic pattern complicates any blanket advice about caffeine and immune function.

Rheumatoid Arthritis

Rheumatoid arthritis (RA) is the autoimmune condition where coffee has gotten the worst reputation, and the evidence here is genuinely messy. A meta-analysis pooling data from both cohort and case-control studies found that higher coffee intake was associated with a roughly 20% increase in RA risk overall. When the analysis was split by disease type, coffee was linked to a roughly 30% higher risk of seropositive RA (the antibody-positive form) but showed no meaningful association with seronegative RA.⁵

Here is where it gets interesting: the same meta-analysis found no significant link between caffeinated coffee specifically and RA risk. And decaffeinated coffee showed no clear association either. That raises the question of whether something else about coffee-drinking habits, or about the people who drink a lot of coffee, is driving the signal. A large Swedish case-control study dug into this and found that the apparent association between heavy coffee drinking (six or more cups a day) and RA largely disappeared once they adjusted for smoking. In the fully adjusted model, the link was small and not statistically significant.⁶ Since heavy coffee drinkers are historically more likely to also be smokers, and smoking is an established RA risk factor, the observed coffee-RA link may be at least partly a case of guilt by association.

An earlier study from the Iowa Women’s Health Study added another twist: women who drank four or more cups of decaffeinated coffee per day had more than double the risk of RA, while women who drank three or more cups of tea daily actually had a substantially lower risk.⁷ Caffeinated coffee and total caffeine intake were not associated with RA at all. That finding points away from caffeine itself as the culprit and toward something else in coffee, or in the processing of decaffeinated coffee, that might matter. Researchers have speculated about chemical solvents used in decaffeination or other bioactive compounds, but no one has pinned it down.

Multiple Sclerosis

The MS story is almost the reverse of the RA narrative. A recent meta-analysis found that coffee drinkers had a meaningfully lower risk of developing MS, with the protective association growing stronger after adjusting for confounders.⁸ The heterogeneity across studies was high, meaning the size of the protective effect varied a lot, but the direction was consistent.

Animal research offers some mechanistic backing. In a widely used animal model of MS, caffeine-treated rats developed the disease less often and showed less brain inflammation, less nerve-fiber damage, and milder symptoms than untreated animals.⁹ A separate study in mice found that caffeine reduced neuroinflammation by inhibiting a specific inflammatory complex (the NLRP3 inflammasome) in brain immune cells, through a mechanism involving cellular self-cleaning called autophagy.¹⁰ The brain is one of caffeine’s primary targets, and its anti-inflammatory effects in neural tissue appear to be relatively consistent across studies, which may explain why MS, a disease of the central nervous system, seems to respond differently from joint-centered conditions like RA.

Inflammatory Bowel Disease

For people with ulcerative colitis (UC) or Crohn’s disease (CD), caffeine anxiety is common. A Mendelian randomization study, which uses genetics to approximate a randomized trial, found that people with genetically higher caffeine levels in their blood had a roughly 20% lower risk of developing IBD, and that reduction was similar for both UC and Crohn’s.¹¹ Other evidence points in the same general direction. Systematic reviews have found coffee and tea intake associated with lower UC rates, and UC patients who regularly drank coffee had lower levels of a stool marker of intestinal inflammation.¹²

But lived experience tells a more divided story, and the split between UC and Crohn’s is striking. In a patient survey, about 20% of UC patients said coffee made their symptoms worse, while roughly 45% of Crohn’s patients said the same.¹³ Coffee is a known gut stimulant. Even if caffeine itself does not promote intestinal inflammation, its effects on motility, acid secretion, and gastric emptying can trigger discomfort in people with active disease, particularly in the small bowel where Crohn’s tends to concentrate. The distinction between whether caffeine worsens the underlying disease process and whether it worsens symptoms on a given day matters a lot here. The epidemiological evidence suggests caffeine is not driving IBD pathology, but plenty of people with IBD, especially Crohn’s, feel worse after a cup of coffee.

Lupus

The evidence for systemic lupus erythematosus (SLE) is surprisingly encouraging. In a study of lupus patients, higher caffeine consumption correlated with lower disease activity scores, and patients who consumed more caffeine had lower blood levels of several inflammatory cytokines, including IFN-gamma, IL-17, IL-6, and IFN-alpha.¹⁴ Low caffeine intake was associated with higher rates of kidney involvement, neuropsychiatric symptoms, and blood abnormalities. Patients who consumed little caffeine were also more likely to be on steroids. This is observational data, so it is possible that sicker patients simply avoided caffeine because they felt worse, rather than caffeine intake directly reducing disease severity. But the cytokine data is harder to dismiss as a behavioral artifact.

Caffeine also appeared to benefit the blood vessel lining in lupus patients. Researchers found a positive correlation between daily caffeine intake and the percentage of endothelial progenitor cells, which help repair damaged blood vessels, a significant concern in lupus where cardiovascular complications are common.¹⁵ A broader review of coffee and autoimmunity, published in 2017, concluded that no significant association had been found between coffee consumption and lupus risk one way or the other, though the evidence at that time was limited.¹⁶

Psoriasis and Autoimmune Liver Disease

Psoriasis patients who drank coffee had lower clinical severity scores than non-drinkers, with the sweet spot appearing to be around three cups per day. At four or more cups, severity scores ticked back up, hinting again at a dose-dependent pattern.¹⁷ The same study found that metabolic syndrome, which is more common in psoriasis patients, was also less prevalent among moderate coffee drinkers. Non-smokers who drank three cups a day had the best odds for lower disease severity.

For autoimmune hepatitis (AIH), the pattern was consistent with what has been seen in other liver diseases. Patients with AIH were significantly less likely to be current coffee drinkers and reported lower lifetime coffee consumption than matched controls. This association held even after accounting for other variables.¹⁸ A Mendelian randomization study further supported a potential causal link, finding that genetically predicted lower coffee intake was associated with higher AIH risk.¹⁹ Coffee’s well-documented hepatoprotective effects, which extend to fatty liver disease and cirrhosis from other causes, likely play a role here.

The Methotrexate Question

For anyone taking methotrexate, one of the most widely prescribed drugs for RA, psoriasis, and other autoimmune conditions, caffeine’s interaction with the drug is a legitimate practical concern. Methotrexate works partly through adenosine pathways, and since caffeine blocks adenosine receptors, there is a plausible mechanism by which caffeine could undercut the drug’s effectiveness. Laboratory research confirmed this concern at the molecular level, showing that caffeine and a related compound interfere with a T-cell signaling pathway that methotrexate targets.²⁰

However, the clinical studies done so far have been reassuring. A study of RA patients on high-dose methotrexate found no difference in disease activity scores between those who consumed caffeine and those who did not.²¹ Similarly, in psoriasis and psoriatic arthritis patients, no correlation was found between caffeine consumption and the dose of methotrexate needed to control disease.²² The gap between the lab findings and the clinical data is notable but not unusual. The concentrations of caffeine used in cell studies often do not match what actually reaches tissues from a few cups of coffee. If you are on methotrexate, this is worth discussing with your rheumatologist, but the current patient-level evidence does not support cutting out coffee.

Coffee and Thyroid Medication Absorption

Autoimmune thyroid disease (Hashimoto’s thyroiditis and Graves’ disease) is among the most common autoimmune conditions, and many patients take daily levothyroxine. Coffee has a well-documented ability to interfere with levothyroxine absorption. In both patients and healthy volunteers, coffee consumed alongside the medication reduced the absorption of thyroxine by roughly 30% and delayed peak absorption by about 40 minutes.²³ This is not about caffeine worsening the autoimmune disease itself. It is about caffeine reducing the effectiveness of a medication that millions of people depend on.

The standard recommendation is to wait at least 30 to 60 minutes after taking levothyroxine before drinking coffee. Some endocrinologists suggest a liquid or gel-cap formulation of levothyroxine for patients who cannot reliably separate their morning coffee from their medication, as these formulations appear less susceptible to food and drink interference. If your thyroid levels have been difficult to stabilize and you take your medication with or near coffee, the timing alone may be the fix.

What Is in the Cup Besides Caffeine

Most of the research discussed above involves coffee consumption, not purified caffeine pills, and coffee contains hundreds of bioactive compounds beyond caffeine. Chlorogenic acid, a major polyphenol in coffee, has strong antioxidant and anti-inflammatory properties in its own right.²⁴ Many of the protective associations seen in studies may reflect coffee’s full chemical profile, not caffeine alone. This is one reason the RA meta-analysis finding, that caffeinated coffee by itself showed no significant link to RA risk, is telling. If caffeine were the main driver, caffeinated coffee should have shown the strongest association, and it did not.

Coffee also affects the gut microbiome. Long-term consumption has been associated with increases in bacteria that produce short-chain fatty acids, which support the gut barrier and have broad anti-inflammatory effects.²⁵ For autoimmune diseases where gut permeability and microbiome composition are increasingly recognized as relevant factors, this is an underappreciated piece of the puzzle. Tea, energy drinks, and caffeine tablets obviously do not carry the same microbial or polyphenol effects, which means advice about “caffeine and autoimmunity” is somewhat incomplete if it ignores the delivery vehicle.

How Your Genetics Shape the Response

Not everyone metabolizes caffeine at the same rate. The speed at which your liver breaks down caffeine depends largely on variants in a gene called CYP1A2 and its regulator AHR. These variants sort people into slow and fast metabolizers, with meaningful consequences for how long caffeine lingers in the bloodstream and how strongly it acts.²⁶ A slow metabolizer who drinks three cups of coffee may sustain blood caffeine levels that a fast metabolizer would only reach at five or six cups. This variability is part of why population-level studies on caffeine and disease can show such inconsistent results. The same number of cups means different things in different bodies.

For someone with an autoimmune condition trying to decide whether to cut back on caffeine, genetic testing for CYP1A2 status is commercially available and relatively inexpensive. While no study has directly tested whether slow metabolizers with autoimmune disease do worse with caffeine, the logic is straightforward: if caffeine’s immune effects are dose-dependent, as the cell-culture research suggests, then your effective dose depends on how quickly your body clears it.

Caffeine, Cortisol, and Sleep

One indirect way caffeine can affect autoimmune disease is through its impact on the stress hormone cortisol. In people who had abstained from caffeine for five days, reintroduction caused a strong cortisol spike. Regular caffeine users still showed elevated cortisol in the afternoons after their second dose, even though the morning spike was blunted.²⁷ Cortisol is a natural immune suppressor, and in autoimmune disease the relationship is complicated: acute cortisol elevation can dampen a flare, but chronically elevated cortisol disrupts immune regulation over time. People who are already under psychological stress showed even more persistent cortisol elevations when caffeine was added.²⁸

Then there is sleep. Caffeine’s most obvious physiological effect is keeping you awake, and poor sleep is itself a risk factor for autoimmune disease progression. Sleep deprivation has been linked to increased autoantibody levels in lupus patients and to disease flares in autoimmune arthritis.²⁹ If afternoon or evening caffeine is costing you an hour of sleep, the immune consequences of that lost sleep could easily outweigh whatever direct anti-inflammatory benefit the caffeine itself provides. For most people with autoimmune disease, paying attention to caffeine timing matters as much as paying attention to caffeine quantity. A morning cup that does not disrupt your sleep carries a very different risk profile than a late-afternoon espresso that shaves 45 minutes off your night.